Amulet Capital, a healthcare-focused specialist, is running a process to move its stake in portfolio company US Fertility into a continuation vehicle as it works to grow the business alongside new partner L Catterton, four sources familiar with the matter told affiliate title Secondaries Investor.
Healthcare specialist Amulet Capital runs CV-on-CV process for US Fertility
The single-asset process is part of what looks to be record-setting secondaries activity this year that appears headed for more than $200bn of total volume.
